{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:42:04Z","timestamp":1790916124631,"version":"4.1.0"},"reference-count":40,"publisher":"American Diabetes Association","issue":"3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>The role of ubiquitin-proteasome system in the accelerated atherosclerotic progression of diabetic patients is unclear. We evaluated ubiquitin-proteasome activity in carotid plaques of asymptomatic diabetic and nondiabetic patients, as well as the effect of rosiglitazone, a peroxisome proliferator\u2013activated receptor (PPAR)-\u03b3 activator, in diabetic plaques. Plaques were obtained from 46 type 2 diabetic and 30 nondiabetic patients undergoing carotid endarterectomy. Diabetic patients received 8 mg rosiglitazone (n = 23) or placebo (n = 23) for 4 months before scheduled endarterectomy. Plaques were analyzed for macrophages (CD68), T-cells (CD3), inflammatory cells (HLA-DR), ubiquitin, proteasome 20S activity, nuclear factor (NF)-\u03baB, inhibitor of \u03baB (I\u03baB)-\u03b2, tumor necrosis factor (TNF)-\u03b1, nitrotyrosine, matrix metalloproteinase (MMP)-9, and collagen content (immunohistochemistry and enzyme-linked immunosorbent assay). Compared with nondiabetic plaques, diabetic plaques had more macrophages, T-cells, and HLA-DR+ cells (P &amp;lt; 0.001); more ubiquitin, proteasome 20S activity (TNF-\u03b1), and NF-\u03baB (P &amp;lt; 0.001); and more markers of oxidative stress (nitrotyrosine and O2\u2212 production) and MMP-9 (P &amp;lt; 0.01), along with a lesser collagen content and I\u03baB-\u03b2 levels (P &amp;lt; 0.001). Compared with placebo-treated plaques, rosiglitazone-treated diabetic plaques presented less inflammatory cells (P &amp;lt; 0.01); less ubiquitin, proteasome 20S, TNF-\u03b1, and NF-\u03baB (P &amp;lt; 0.01); less nitrotyrosine and superoxide anion production (P &amp;lt; 0.01); and greater collagen content (P &amp;lt; 0.01), indicating a more stable plaque phenotype. Similar findings were obtained in circulating monocytes obtained from the two groups of diabetic patients and cultured in the presence or absence of rosiglitazone (7.0 \u03bcmol\/l). Ubiquitin-proteasome over-activity is associated with enhanced inflammatory reaction and NF-\u03baB expression in diabetic plaques. The inhibition of ubiquitin-proteasome activity in atherosclerotic lesions of diabetic patients by rosiglitazone is associated with morphological and compositional characteristics of a potential stable plaque phenotype, possibly by downregulating NF-\u03baB-mediated inflammatory pathways.<\/jats:p>","DOI":"10.2337\/diabetes.55.03.06.db05-0832","type":"journal-article","created":{"date-parts":[[2006,5,8]],"date-time":"2006-05-08T22:24:54Z","timestamp":1147127094000},"page":"622-632","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":98,"title":["The Ubiquitin-Proteasome System and Inflammatory Activity in Diabetic Atherosclerotic Plaques"],"prefix":"10.2337","volume":"55","author":[{"given":"Raffaele","family":"Marfella","sequence":"first","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"},{"name":"Cardiovascular Research Center, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Second University Naples, Naples, Italy"},{"name":"Department of Experimental Medicine, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"},{"name":"Cardiovascular Research Center, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Baldi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Section of Pathology, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Di Filippo","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Second University Naples, Naples, Italy"},{"name":"Department of Experimental Medicine, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Siniscalchi","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferndinando Carlo","family":"Sasso","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Portoghese","sequence":"additional","affiliation":[{"name":"Cardiovascular Surgery Unit, Sassari Hospital, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cirillo","sequence":"additional","affiliation":[{"name":"Cardiovascular Unit, Hospital V. Monaldi, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cacciapuoti","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Carbonara","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilio","family":"Crescenzi","sequence":"additional","affiliation":[{"name":"Cardiovascular Unit, Hospital V. Monaldi, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciano","family":"Baldi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Section of Pathology, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medicine, Experimental and Clinical, University of Udine, Udine, Italy"},{"name":"Department of Surgery, Second University of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Francesco","family":"Nicoletti","sequence":"additional","affiliation":[{"name":"Department of Surgery, Second University of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D\u2019Andrea","sequence":"additional","affiliation":[{"name":"Department of Surgery, Second University of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Verza","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"Coppola","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rossi","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Second University Naples, Naples, Italy"},{"name":"Department of Experimental Medicine, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Giugliano","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Metabolic Diseases, Second University Naples, Naples, Italy"},{"name":"Cardiovascular Research Center, Second University Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031208213451200_R1","doi-asserted-by":"crossref","unstructured":"Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation\u2008100:1134\u20131146,1999","DOI":"10.1161\/01.CIR.100.10.1134"},{"key":"2022031208213451200_R2","doi-asserted-by":"crossref","unstructured":"Creager MA, Luscher TF, Cosentino F, Beckman JA: Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation\u2008108:1527\u20131532,2003","DOI":"10.1161\/01.CIR.0000091257.27563.32"},{"key":"2022031208213451200_R3","doi-asserted-by":"crossref","unstructured":"Herrmann J, Ciechanover A, Lerman LO, Lerman A: The ubiquitin-proteasome system in cardiovascular diseases: a hypothesis extended. Cardiovasc Res\u200861:11\u201321,2004","DOI":"10.1016\/j.cardiores.2003.09.033"},{"key":"2022031208213451200_R4","doi-asserted-by":"crossref","unstructured":"Hershko A, Ciechanover A, Varshavsky A: Basic medical research award: the ubiquitin system. Nat Med\u20086:1073\u20131081,2000","DOI":"10.1038\/80384"},{"key":"2022031208213451200_R5","doi-asserted-by":"crossref","unstructured":"Coux O, Tanaka K, Goldberg AL: Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem\u200865:801\u2013847,1996","DOI":"10.1146\/annurev.bi.65.070196.004101"},{"key":"2022031208213451200_R6","doi-asserted-by":"crossref","unstructured":"Palombella VJ, Rando OJ, Goldberg AL, Maniatis T: The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell\u200878:773\u2013785,1994","DOI":"10.1016\/S0092-8674(94)90482-0"},{"key":"2022031208213451200_R7","doi-asserted-by":"crossref","unstructured":"Lecker SH, Solomon V, Price SR, Kwon YT, Mitch WE, Goldberg AL: Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. J Clin Invest\u2008104:1411\u20131420,1999","DOI":"10.1172\/JCI7300"},{"key":"2022031208213451200_R8","doi-asserted-by":"crossref","unstructured":"Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona, P: Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab\u200889:2728\u20132735,2004","DOI":"10.1210\/jc.2003-032103"},{"key":"2022031208213451200_R9","doi-asserted-by":"crossref","unstructured":"Motomura W, Takahashi N, Nagamine M, Sawamukai M, Tanno S, Kohgo Y, Okumura T: Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Int J Cancer\u2008108:41\u201346,2004","DOI":"10.1002\/ijc.11561"},{"key":"2022031208213451200_R10","doi-asserted-by":"crossref","unstructured":"Young B, Moore WS, Robertson JT, Toole JF, Ernst CB, Cohen SN, Broderick JP, Dempsey RJ, Hosking JD: An analysis of perioperative surgical mortality and morbility in the Asymptomatic Carotid Atherosclerosis Study. Stroke\u200827:2216\u20132224,1996","DOI":"10.1161\/01.STR.27.12.2216"},{"key":"2022031208213451200_R11","doi-asserted-by":"crossref","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care\u200826:3160\u20133167,2003","DOI":"10.2337\/diacare.26.11.3160"},{"key":"2022031208213451200_R12","doi-asserted-by":"crossref","unstructured":"Minamikawa J, Tanaka S, Yamauchi M, Inoue D, Koshiyama H: Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab\u200883:1818\u20131820,1998","DOI":"10.1210\/jcem.83.5.4932"},{"key":"2022031208213451200_R13","doi-asserted-by":"crossref","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia\u200828:412\u2013419,1985","DOI":"10.1007\/BF00280883"},{"key":"2022031208213451200_R14","doi-asserted-by":"crossref","unstructured":"Ohlsson BG, Englund MCO, Karlsson ALK, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O: Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kB to DNA and the subsequent expression of tumor necrosis factor-\u03b1 and interleukin-1\u03b2 in macrophages. J Clin Invest\u200898:78\u201389,1996","DOI":"10.1172\/JCI118780"},{"key":"2022031208213451200_R15","doi-asserted-by":"crossref","unstructured":"de Vries HE, Buchner B, van Berkel TJ, Kuiper J: Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol\u200819:638\u2013645,1999","DOI":"10.1161\/01.ATV.19.3.638"},{"key":"2022031208213451200_R16","doi-asserted-by":"crossref","unstructured":"Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, Pia Di Marino M, Baldi A, Cuzzocrea S, Di Filippo C, Barboso G, Baldi F, Rossi F, D\u2019Amico M, Giugliano D: Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes\u200853:2383\u20132391,2004","DOI":"10.2337\/diabetes.53.9.2383"},{"key":"2022031208213451200_R17","doi-asserted-by":"crossref","unstructured":"Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A: The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation\u2008108:1070\u20131077,2003","DOI":"10.1161\/01.CIR.0000086014.80477.0D"},{"key":"2022031208213451200_R18","doi-asserted-by":"crossref","unstructured":"Herrmann J, Edwards WD, Holmes DR Jr: Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes. J Am Coll Cardiol\u200840:1919\u20131927,2002","DOI":"10.1016\/S0735-1097(02)02564-0"},{"key":"2022031208213451200_R19","doi-asserted-by":"crossref","unstructured":"Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R: Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol\u200824:1266\u201371,2004","DOI":"10.1161\/01.ATV.0000131783.74034.97"},{"key":"2022031208213451200_R20","doi-asserted-by":"crossref","unstructured":"Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol\u200810:405\u2013455,1994","DOI":"10.1146\/annurev.cb.10.110194.002201"},{"key":"2022031208213451200_R21","doi-asserted-by":"crossref","unstructured":"Herrmann J, Gulati R, Napoli C, Woodrum JE, Lerman LO, Rodriguez-Porcel M, Sica V, Simari RD, Ciechanover A, Lerman A: Oxidative stress-related increase in ubiquitination in early coronary atherosclerosis. FASEB J\u200817:1730\u20131732,2003","DOI":"10.1096\/fj.02-0841fje"},{"key":"2022031208213451200_R22","doi-asserted-by":"crossref","unstructured":"Ross R. Atherosclerosis: an inflammatory disease: N Engl J Med\u2008340:115\u2013126,1999","DOI":"10.1056\/NEJM199901143400207"},{"key":"2022031208213451200_R23","doi-asserted-by":"crossref","unstructured":"Anwar A, Zahid AA, Scheidegger KJ, Brink M, Delafontaine P: Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation\u2008105:1220\u20131225,2002","DOI":"10.1161\/hc1002.105187"},{"key":"2022031208213451200_R24","doi-asserted-by":"crossref","unstructured":"Ceriello A, Motz E: Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol\u200824:816\u2013823,2004","DOI":"10.1161\/01.ATV.0000122852.22604.78"},{"key":"2022031208213451200_R25","doi-asserted-by":"crossref","unstructured":"Roebuck KA: Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int J Mol Med\u20084:223\u2013230,1999","DOI":"10.3892\/ijmm.4.3.223"},{"key":"2022031208213451200_R26","doi-asserted-by":"crossref","unstructured":"Ishii T, Itoh K, Sato H, Bannai S: Oxidative stress-inducible proteins in macrophages. Free Radic Res\u200831:351\u20135,1999","DOI":"10.1080\/10715769900300921"},{"key":"2022031208213451200_R27","doi-asserted-by":"crossref","unstructured":"Kikuchi J, Furukawa Y, Kubo N: Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis. Arterioscler Thromb Vasc Biol\u200820:128\u201334,2000","DOI":"10.1161\/01.ATV.20.1.128"},{"key":"2022031208213451200_R28","doi-asserted-by":"crossref","unstructured":"Hwang GW, Furuchi T, Naganuma A: A ubiquitin-proteasome system is responsible for the protection of yeast and human cells against methylmercury. FASEB J\u200816:709\u2013711,2002","DOI":"10.1096\/fj.01-0899fje"},{"key":"2022031208213451200_R29","doi-asserted-by":"crossref","unstructured":"Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest\u200894:2493\u20132503,1994","DOI":"10.1172\/JCI117619"},{"key":"2022031208213451200_R30","doi-asserted-by":"crossref","unstructured":"Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr: Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA\u2008292:1845\u201352,2004","DOI":"10.1001\/jama.292.15.1845"},{"key":"2022031208213451200_R31","doi-asserted-by":"crossref","unstructured":"Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI: Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation\u2008106:679\u2013684,2002","DOI":"10.1161\/01.CIR.0000025403.20953.23"},{"key":"2022031208213451200_R32","doi-asserted-by":"crossref","unstructured":"Sidhu JS, Cowan D, Kaski JC: Rosiglitazone reduces endothelial cell activation, C-reactive protein and fibrinogen levels in non-diabetic coronary artery disease patients. J Am Coll Cardiol\u200842:1757\u20131763,2003","DOI":"10.1016\/j.jacc.2003.04.001"},{"key":"2022031208213451200_R33","doi-asserted-by":"crossref","unstructured":"Marx N, Libby P, Plutzky J: Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?J Cardiovasc Risk\u20088:203\u2013210,2001","DOI":"10.1177\/174182670100800404"},{"key":"2022031208213451200_R34","doi-asserted-by":"crossref","unstructured":"Barbier O, Torra IP, Duguay Y: Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol\u200822:717\u2013726,2002","DOI":"10.1161\/01.ATV.0000015598.86369.04"},{"key":"2022031208213451200_R35","unstructured":"Sidhu JS, Kaski JC: Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease. Heart\u200886:255\u2013258,2001"},{"key":"2022031208213451200_R36","doi-asserted-by":"crossref","unstructured":"Takeuchi S, Okumura T, Motomura W, Nagamine M, Takahashi N, Kohgo Y: Troglitazone induces G1 arrest by p27(Kip1) induction that is mediated by inhibition of proteasome in human gastric cancer cells. Jpn J Cancer Res\u200893:774\u2013782,2002","DOI":"10.1111\/j.1349-7006.2002.tb01319.x"},{"key":"2022031208213451200_R37","doi-asserted-by":"crossref","unstructured":"Howard G, O\u2019Leary DH, Zaccaro D: Insulin sensitivity and atherosclerosis. Circulation\u200893:1809\u20131817,1996","DOI":"10.1161\/01.CIR.93.10.1809"},{"key":"2022031208213451200_R38","doi-asserted-by":"crossref","unstructured":"Ogihara T, Asano T, Katagiri H, Sakoda H, Anai M, Shojima N, Ono H, Fujishiro M, Kushiyama A, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Gotoh Y, Komuro I, Fujita T: Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia\u200847:794\u2013805,2004","DOI":"10.1007\/s00125-004-1391-x"},{"key":"2022031208213451200_R39","doi-asserted-by":"crossref","unstructured":"Petrova TV, Akama KT, Van Elkdik LJ: Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-\u03b412,14-prostaglandin J2. Proc Natl Acad Sci U S A\u200896:4668\u20134673,1999","DOI":"10.1073\/pnas.96.8.4668"},{"key":"2022031208213451200_R40","doi-asserted-by":"crossref","unstructured":"Neurath MF, Pettersson S, Buschenfelde KHM, Strober W: Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-\u03baB abrogates established experimental colitis in mice. Nat Med\u20082:998\u20131004,1996","DOI":"10.1038\/nm0996-998"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/55\/3\/622\/651370\/zdb00306000622.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/55\/3\/622\/651370\/zdb00306000622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:28:40Z","timestamp":1667406520000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/55\/3\/622\/12663\/The-Ubiquitin-Proteasome-System-and-Inflammatory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.55.03.06.db05-0832","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}